| Date | Title | Description |
| 17.09.2026 | Dr. Alison Armour agrees to become Chief Medical Officer of Alpha Fusion, as Company Advances Integration of At-211 Businesses with Curadh MTR | — Combining Both Companies' Astatine At-211 Assets, Development Capabilities, and Supply Chains to Create a Global Targeted Alpha Therapy Company —
TOKYO, Sept. 17, 2026 /PRNewswire/ -- Alpha Fusion Inc. ("Alpha Fusion"), a clinic... |
| 10.09.2026 | Novo Holdings invests in ForYou Medical to support global growth in advanced wound care manufacturing | SINGAPORE, Sept. 10, 2026 /PRNewswire/ -- Novo Holdings, a leading global healthcare and life sciences investor, today announced a strategic minority investment in Huizhou ForYou Medical Devices Co., Ltd. ("ForYou Medical"), a Chi... |
| 09.09.2026 | Novartis-Pfizer trademark deal has opposite impact on their stock prices; Novartis India jumps 20% while Pfizer slips 3% | - |
| 09.09.2026 | Oil prices keep rising and weigh on Wall Street | Getting your Trinity Audio player ready...
By STAN CHOE, AP Business Writer
NEW YORK (AP) — U.S. stocks fell Tuesday in their return to trading from a three-day weekend after the latest fighting in the war with Iran pushed oil prices higher... |
| 01.09.2026 | Novartis Halts Autoimmune CAR-T Studies Following Fatal Cases | - |
| 21.08.2026 | Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ) | Notice to Extraordinary General Meeting in Hansa Biopharma AB (publ)
Fri, Aug 21, 2026 07:30 CET Report this content
Lund, Sweden August 21, 2026, Hansa Biopharma AB (publ), Reg. No. 556734-5359 (“Hansa Biopharma”), with registered office i... |
| 20.08.2026 | Bristol Myers Squibb Partners with Chai Discovery for AI Antibody Design | What You Should Know
Chai Discovery announced a strategic biopharmaceutical collaboration with Bristol Myers Squibb (BMS) to advance the discovery and engineering of therapeutic antibodies using artificial intelligence.
Bristol Myers Squibb... |
| 19.08.2026 | Российская фармкомпания стала лидером по выплатам врачам и медорганизациям | Российская фармкомпания стала лидером по выплатам врачам и медорганизациям Иностранные игроки все меньше тратят на исследования
«Р-Фарм» потратил на выплаты врачам и организациям в 2025 году 2,2 млрд руб., больше, чем любой другой член Ассо... |
| 14.08.2026 | Pharmaceuticals Market Trends: Innovation, Rising Healthcare Demand, and Advanced Therapies Driving Growth | The pharmaceuticals market is witnessing strong growth as rising healthcare needs, increasing disease prevalence, expanding access to medicines, and continuous innovation in drug development drive global demand. Pharmaceutical products play... |
| 12.08.2026 | Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets | Cycle Pharmaceuticals (“Cycle”), a global pharmaceutical company focused on rare diseases, and Forma Life Sciences, Inc. (“Forma”), a U.S. contract development and manufacturing organization, today announced a commercial manufacturing agree... |
| 12.08.2026 | Silent Cancer Therapeutics Market Size to Reach USD 36.52 Billion by 2035, Driven by Precision Oncology and Advanced Cancer Therapies | Overview
According to DataM Intelligence, the global silent cancer therapeutics market size was valued at USD 15.86 billion in 2025 and is forecast to reach USD 36.52 billion by 2035, expanding at a CAGR of 8.7% during 2026 to 2035. The mar... |
| 11.08.2026 | Quantified Named One of the Fastest-Growing AI & Data Companies on the Inc. 5000 List for the Second Consecutive Year | For the second consecutive year, Quantified lands on the Inc. 5000 list, fueled by growing adoption among top global pharma companies looking to keep commercial teams compliant, certified, coached, and ready to perform.
AUSTIN, Texas, Aug. ... |
| 11.08.2026 | ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer | ILiAD Biotechnologies, Inc. (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella pertussis, today announced the appointments of Jim Wassil, currently Chief Operating Off... |
| 06.08.2026 | Manufacturing Jobs Flock to the U.S. Thanks to President Trump’s America First Economic Agenda | With President Trump’s economic agenda taking effect, the United States is seeing an economic revival across our manufacturing industry. July saw the strongest expansion in domestic manufacturing activity in more than four years, marking se... |
| 05.08.2026 | Natco challenges Novartis’s second patent for cancer drug ribociclib in Delhi High Court | - |
| 29.07.2026 | Novartis chart may soon ‘complete a well-defined bullish reversal,’ Cappelleri says | - |
| 28.07.2026 | Torrey Pines Medicine Secures Angel Round to Advance Next-Generation Ultra-Long-Acting Peptide Therapeutics | Led by Lotus Lake Capital, the financing will accelerate the development of TPM004, a differentiated ultra-long-acting amylin/calcitonin receptor dual agonist, and advance the company's proprietary PepTetris™ peptide discovery platform for ... |
| 21.07.2026 | Stocks making the biggest moves premarket: General Motors, 3M, Novartis, Nebius & more | - |
| 20.07.2026 | Dow gains nearly 400 points; S&P 500 snaps 3-day losing run as chip stocks rise | Stocks climbed on Tuesday, supported by chipmakers, as investors looked through the latest developments in the Iran war to focus on corporate earnings updates.
The Dow Jones Industrial Average rose 385.38 points, or 0.74%, to 52,224.64. The... |
| 20.07.2026 | PharmaBlock Convenes Global Industry Leaders in Zurich to Advance Green Chemistry for Sustainable Pharmaceutical Manufacturing | ZURICH, July 20, 2026 /PRNewswire/ -- As Europe experienced one of its hottest Junes on record, with prolonged heatwaves reinforcing the urgency of climate action, leaders from the pharmaceutical industry and academia gathered in Zurich for... |
| 16.07.2026 | Wearable Medical Devices Market Set for Strong Growth as Digital Healthcare Adoption Accelerates | Wearable Medical Devices Market Europe is expected to reach US$ 9.80 Bn. at a CAGR of 18.8 during the forecast period 2029.
Wearable Medical Devices Market Overview:
Maximize Market Research is a Business Consultancy Firm that has published... |
| 15.07.2026 | ACROBiosystems Obtains PMDA Material Suitability Confirmation for GMP-grade IL-15, Ensuring Reliable Quality and Strengthening the Biopharmaceutical Approval Process | NEWARK, Del., July 15, 2026 /PRNewswire/ -- Recently, ACROBiosystems has officially received the "Material Suitability Confirmation for Regenerative Medicine Products" (Certificate No.: 薬機審長発第47号) from the Pharmaceuticals and Medi... |
| 14.07.2026 | Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma | Chai Discovery Inc., a company that develops artificial intelligence models to predict interactions between biochemical molecules, today announced it has raised $400 million in new funding, nearly tripling its valuation to $3.8 billion.
Ind... |
| 11.07.2026 | Global Headlines Roar: Trump's FIFA Move, Soaring Markets, and Geopolitical Shifts | President Trump executed an unprecedented FIFA intervention, overturning a World Cup red card for US striker Folarin Balogun. Prediction markets surged with billions in trading volume. Wall Street futures pointed to new highs post-holiday. ... |
| 10.07.2026 | ChrysCapital’s open offer for Novartis India fails as shares surge | The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann
Homegrown private equity firm ChrysCapital’s open offer to acquire additional shares of Novartis India Ltd has found no takers as the drugmaker’s share... |
| 09.07.2026 | Immunotherapy Drugs Market to Reach $580.6 Billion by 2029 | The global Immunotherapy drugs market is projected to grow from USD 285.3 billion in 2024 to USD 580.6 billion by 2029, at a robust CAGR of 15.3% during the forecast period. Market growth is driven by advancements in antibody engineering te... |
| 09.07.2026 | Flare Therapeutics Secures $85M Series C Round |
CAMBRIDGE, MA, Flare Therapeutics, a clinical-stage biotechnology company, announced the closing of an $85 million Series C financing.
>> Click here for more funding data on Flare Therapeutics
>> To export Flare Therapeutics fu... |
| 07.07.2026 | BIOHK2026 (Hong Kong International Biotechnology Conference and Exhibition), 9-12 September, Hong Kong - Connecting Global Leaders in Biotechnology | Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong Kong this September.
HONG KONG, July 7, 2026 /PRNewswire/ -- The 5th Hong Kong International Biotechnology Conferenc... |
| 06.07.2026 | Онкопациенты выше всего оценили репутацию Roche, AstraZeneca и Novartis | Онкопациенты выше всего оценили репутацию Roche, AstraZeneca и Novartis
Исследовательская компания PatientView представила ежегодный рейтинг репутации фармкомпаний в онкологии. В нем 505 пациентских организаций из разных стран, работающих в... |
| 06.07.2026 | CNBC Daily Open: Trump sees red, prediction markets score and NATO’s defensive | President Donald Trump thanks FIFA for overturning U.S. striker Folarin Balogun’s red card.
A report suggests European body UEFA could challenge the red card suspension.
Norway defeats Brazil, and England scores a victory against Mexico to ... |
| 06.07.2026 | Patent cliff fuels Novartis’ $1.5bn swoop for London biotech | Swiss pharmaceutical giant Novartis has agreed to buy London-based biotech Myricx Bio for up to $1.5bn (£1.1bn) as global drugmakers continue deploying billions into promising biotech firms ahead of an estimated $450bn wave of patent expiri... |
| 03.07.2026 | Sky Labs Showcases 'CART BP pro' for Potential Use in Drug Clinical Trials on Global Stage | BASEL, Switzerland and SEOUL, South Korea, July 3, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 2nd that it introduced its data platform business at the 9th Digital Biomarkers in Clinical Trials Summit in Basel, S... |
| 02.07.2026 | Biotech and Food companies strengthen management teams on the business side |
Basel-based pharma company Idorsia has appointed Roland Wandeler as CEO, effective October 1, 2026. He will succeed Jean-Paul Clozel, who has been serving as ad interim CEO since March 2026 and will continue as Chairman of the Board of Dir... |
| 29.06.2026 | Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 29, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ther... |
| 24.06.2026 | Yidu Tech's Gong Yingying at Summer Davos: Building Evidence Infrastructure to Expand Access to Innovative Medicines | DALIAN, China, June 24, 2026 /PRNewswire/ -- On June 23, at the 17th Annual Meeting of the New Champions (Summer Davos 2026) hosted by the World Economic Forum in Dalian, Gong Yingying, Founder and Chairlady of Yidu Tech, participated in th... |
| 22.06.2026 | BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic’s BrainTransporter™ technology | BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic’s BrainTransporter™ technology
Mon, Jun 22, 2026 07:32 CET Report this content
Stockholm, Sweden, June 22, 2026 – BioArctic AB (publ) (Nas... |
| 19.06.2026 | U.S. opens tariff probe targeting Germany’s drug pricing policies | The U.S. said the probe will examine whether “persistent underpayment” for medicines by Germany is discriminatory.
“President Trump has made clear that American patients should not be shouldering a disproportionate share of global pharmaceu... |
| 17.06.2026 | FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin | Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy
BASEL, Switzerland, June 17, 2026 /PRNewswire/ -- FiberSense AG ("FiberSense") today announced that ... |
| 16.06.2026 | 2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy | Revolutionizing Treatments for Blood Cancers and Solid Tumors
TAIPEI, June 16, 2026 /PRNewswire/ -- On June 16, the Tang Prize in Biopharmaceutical Science announced its 2026 laureates. Three leading scientists in the field of cellular immu... |
| 16.06.2026 | Biotech IPO revival faces competition from cash-rich big pharma buyers | Biotech investors are far more selective than they were during the pandemic-era boom, JPMorgan’s top EMEA healthcare investment bankers told CNBC.
Many biotech companies are now pursuing a dual-track process: preparing for an IPO while simu... |
| 13.06.2026 | Global Heart Hub finds women delay seeking heart care by continuing to put others first | Heart symptoms continue to be dismissed or mistaken for other conditions, such as anxiety, new global patient-led research reveals.
Findings were presented at the European Society of Cardiology's ACNAP Congress 2026, organised by the Associ... |
| 13.06.2026 | Switzerland is voting on whether to cap its population at 10 million. Here’s what to know | Switzerland will hold a referendum on Sunday on whether to cap its population at 10 million people.
If the measure is passed, Swiss officials will have to roll out measures to curb population growth until 2050.
Businesses have warned that l... |
| 12.06.2026 | Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 12, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody ther... |
| 27.05.2026 | AI firm Visium secures funds to scale across Europe and US |
Founded in 2018 in Lausanne, Visium provides AI and data services to companies in regulated industries, primarily life sciences and specialty chemicals. The company runs a dual model that combines consulting with software products, includi... |
| 24.05.2026 | Kordata Dynamics: AI-Powered Precision Clinical Trials Platform Launches With Pre-Seed Backing | Kordata Dynamics has emerged from stealth with the launch of an AI-powered precision clinical trials platform designed to improve the speed, quality, and accessibility of clinical research. The company also announced a pre-seed funding roun... |
| 18.05.2026 | Next Round of China’s Centralized Drug Buying to Cover Record Number of Medicines | (Yicai) May 18 -- The next round of bidding for China’s centralized drug procurement program will cover a record number of more than 70 medicines and 233 dosage forms and strengths.
The figures were released by the National Organization for... |
| 13.05.2026 | Isomorphic Labs Secures $2.1 Billion for AI Drug Discovery Global Scale | Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital injection accelerates its world-leading AI drug design engine, IsoDDE. The company expands globally, fast-tracking its therapeutic pipeline. Isomorphic aims to... |
| 13.05.2026 | Isomorphic Labs Raises $2.1 Billion Series B To Scale AI Drug Design Engine And Advance Therapeutic Pipeline | Isomorphic Labs, the London-based AI-first drug design and development company, has raised $2.1 billion in Series B funding to accelerate its evolution from pioneering novel AI models to applying them at scale. The round is led by Thrive Ca... |
| 13.05.2026 | DeepMind CEO Demis Hassabisâ Isomorphic Labs raises $2.1 billion led by Thrive Capital | Synopsis
AI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of their AI drug design engine and advance therapeutic candidates. The investment underscores st... |
| 12.05.2026 | Isomorphic Labs secures $2.1 Billion funding to scale its AI drug design engine | Isomorphic Labs will use the funding to power its world-leading AI drug design engine, scale its business globally and progress its drug candidate pipeline.
LONDON, May 12, 2026 /PRNewswire/ -- Isomorphic Labs, an AI-first drug design and d... |
| 10.05.2026 | ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D | NEWARK, Del., May 10, 2026 /PRNewswire/ -- ACROBiosystems has implemented a major upgrade to its global licensing framework for HEK293 functional cell lines, transitioning from a complex administrative process to a streamlined, purchase-bas... |
| 09.05.2026 | Googleâs Isomorphic Labs to raise over $2 billion in new funding | Synopsis
Alphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. This significant investment aims to bolster its drug design engine and fuel global expansion... |
| 07.05.2026 | XRHealth Named Winner of the 2026 MedTech Breakthrough Telehealth Innovation Award | XRHealth has been named winner of the 2026 MedTech Breakthrough "Telehealth Innovation Award," selected from more than 5,000 global nominations alongside industry leaders including Noom, Teladoc, and Medtronic. The recognition hig... |
| 06.05.2026 | Professor Saumya Sindhwani of Indian School of Business (ISB) Appointed Provost of Galgotias University | Greater Noida, Uttar Pradesh, India
Galgotias University has appointed Professor Saumya Sindhwani as Provost, adding a senior academic leader with experience across teaching, executive education, organisational development, and institution ... |
| 05.05.2026 | Jeito Capital Bolsters Its Leadership Team With the Appointment of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, as Partner, Talent | Jeito Capital (“Jeito”), a leading global independent private equity fund dedicated to Biopharma, today announces the appointments of Elaine Caughey, MBA, as Partner, Business Development and Investor Relations, and Sarah Shackelton, MPA, a... |
| 30.04.2026 | ACROBiosystems and SeromYx Systems Announce Strategic Collaboration on Comprehensive Functional Profiling of Anti-CD20 Monoclonal Antibodies | TOKYO and NEWARK, Del., April 30, 2026 /PRNewswire/ -- ACROBiosystems, a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries, has entered into a research collaboration with SeromYx Systems, spe... |
| 28.04.2026 | ACROBiosystems Wins CiteAb Award, Gaining Worldwide Recognition | SAN DIEGO and NEWARK, Del., April 28, 2026 /PRNewswire/ -- Recently, ACROBiosystems was honored as a "Protein Supplier to Watch in Cancer Research in 2026" at the CiteAb Awards.
CiteAb accelerates scientific research by providing ... |
| 28.04.2026 | ACROBiosystems Showcases AI-Driven Innovation at AACR 2026, Empowering Next-Generation Biologics Discovery | SAN DIEGO and NEWARK, N.J., April 28, 2026 /PRNewswire/ -- From April 17 to 22, 2026, ACROBiosystems—a company dedicated to being a cornerstone of the global biopharmaceutical and healthcare industries—presented its comprehensive, AI‑driven... |
| 24.04.2026 | Iridius: $8.6 Million Seed Funding Raised To Build Compliance-By-Design AI Platform For Regulated Industries | Iridius, a compliance-by-design AI platform for regulated workflow execution, has raised $8.6 million in seed funding led by Chalfen Ventures, with participation from Osage Venture Partners, Accenture Ventures, and Rock Yard Ventures. Separ... |
| 16.04.2026 | Anthropic appoints Novartis Chief Executive Officer to board | - |
| 09.04.2026 | AI-Powered Pharma Manufacturing Signals Scalable Efficiency, Long-Term Cost Advantages | As regulatory demands intensify and production environments become more complex, pharmaceutical manufacturers are shifting beyond traditional quality assurance systems toward a new operational model: integrating artificial intelligence dire... |
| 30.03.2026 | Blackstone: $6.3 Billion Life Sciences Fund Closed As Largest Private Vehicle In Sector | Blackstone announced the final close of its latest life sciences fund, Blackstone Life Sciences VI, at $6.3 billion, marking the largest private fund ever dedicated to the life sciences sector. The fund reached its hard cap and was oversubs... |
| 27.03.2026 | Global Crossroads: Pharma Shifts and Markets Sway | Wall Street navigates intense volatility. Geopolitical tensions from the ongoing Iran conflict drive market swings. Oil prices ease on perceived de-escalation, yet regional attacks persist. Global stocks post fragile gains. Amid this turbul... |
| 27.03.2026 | Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week | Novartis’ acquisition of U.S.-based Excellergy will add an early-stage drug candidate Exl-111 to the company’s existing allergy portfolio.
It comes just a week after Novartis announced it is acquiring Synnovation subsidiary Pikavation Thera... |
| 27.03.2026 | Швейцарская фармкомпания Novartis купит американскую биотехкомпанию Excellergy за $2 млрд | Novartis планирует приобрести американскую биотехнологическую компанию Excellergy за сумму до $2 млрд, делая ставку на препарат нового поколения для лечения аллергии, который, как ожидается, будет действовать быстрее и эффективнее существую... |
| 25.03.2026 | Merck to buy Terns Pharmaceuticals for $6.7 billion to boost cancer pipeline | Merck will acquire Terns for $53 per share in cash, amounting to an equity value of about $6.7 billion.
This is the third multibillion-dollar acquisition for Merck over the past year as it looks to bulk up its portfolio ahead of its best-se... |
| 18.03.2026 | Breakthrough at 2026 AACR! Senhwa Biosciences' CX-5461 Enters the Field of Photodynamic Therapy, Opening a New Indication Strategy | TAIPEI and SAN DIEGO, March 18, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical stage company focusing on development of first-in-class therapeutics for oncology, rare diseases, and infectious diseases, today announce... |
| 14.03.2026 | ORO Labs Secures $100M to Revolutionize Enterprise AI Procurement | ORO Labs, an AI-driven procurement orchestration leader, secured $100 million in Series C funding. This capital injection follows a year of 300% revenue growth. The platform modernizes enterprise procurement. It streamlines complex global s... |
| 12.03.2026 | ORO Labs: $100 Million Raised For AI-Driven Enterprise Operations | ORO Labs, a procurement orchestration platform for global enterprises, announced it has raised $100 million in Series C funding to accelerate the adoption of agentic orchestration in enterprise procurement. The funding round was led by Brig... |
| 12.03.2026 | Dividend stocks are going gangbusters in 2026. Here’s what investors are doing with the extra cash | - |
| 11.03.2026 | Dify Secures $30M To Propel Open-Source AI Deployment | Dify, a Menlo Park-based innovator, just closed a $30 million Series Pre-A funding round. The valuation now stands at $180 million. The company provides a crucial open-source platform. It enables teams to construct, deploy, and manage produ... |
| 10.03.2026 | Bright spots in tackling AMRs, but drug-resistance outpaces pharma industry efforts: Report | - |
| 10.03.2026 | Dify: $30 Million Raised For Open-Source AI Application Platform In Series Pre-A Round | Dify, a Menlo Park, California-based provider of an open-source platform that helps teams build, deploy, and operate production-grade AI applications and agentic workflows, announced it has raised $30 million in series pre-A funding at a $1... |
| 02.03.2026 | Superior Efficacy and Long-acting: LongBio Announces Positive Topline Results from Phase II CSU Trial of Next-Generation Anti-IgE Therapy, LP-003 in Head-to-Head Comparison with Xolair® | PHILADELPHIA, March 2, 2026 /PRNewswire/ -- LongBio Pharma (Suzhou) Co., Ltd. ("LongBio"), a clinical-stage biotech company focused on discovery and development of biologics targeting allergic and autoimmune diseases, proudly anno... |
| 26.02.2026 | Slate Medicines Secures $130M to Advance Migraine Prevention | Slate Medicines secures $130 million in Series A funding. The Raleigh, NC-based biotech company launched to transform migraine prevention. Its core focus is SLTE-1009, an anti-PACAP monoclonal antibody. This therapy addresses severe headach... |
| 26.02.2026 | Novartis, Genentech file suit alleging illegal importation of prescription drug | Novartis and Genentech are suing a U.S. company and a Canadian pharmacy over the importation of a Canadian version of their allergy medicine.
The importation of the drug, which has strict shipping and temperature controls, potentially puts ... |
| 26.02.2026 | Novartis settles with Henrietta Lacks’ estate over use of her ‘stolen’ cells to advance medicine | Getting your Trinity Audio player ready...
By BRIAN WITTE
Novartis has settled a lawsuit by the estate of Henrietta Lacks that alleged the pharmaceutical giant unjustly profited off her cells, which were taken from her tumor without her kno... |
| 24.02.2026 | Slate Medicines: $130 Million Series A Raised To Advance Anti-PACAP Migraine Therapies | Slate Medicines, a privately held biotech company developing next-generation therapeutics for headache disorders, has launched with the close of a $130 million Series A financing and the in-licensing of SLTE-1009, an anti-PACAP monoclonal a... |
| 20.02.2026 | With Trump’s ‘reciprocal’ tariffs struck down, here are the industries still facing higher rates | President Donald Trump’s so-called reciprocal tariffs were deemed unconstitutional by the Supreme Court, but some sector-specific tariffs will remain in place.
The Supreme Court ruling covered IEEPA tariffs, used for national emergencies ou... |
| 20.02.2026 | ChrysCapital inks $159 mn control deal for Novartis India, makes open offer | The Novartis logo at a building in Rotkreuz, Switzerland | Credit: Reuters/Arnd Wiegmann
Homegrown private equity firm ChrysCapital has agreed to acquire Swiss pharmaceutical major Novartis AG’s entire stake in its Mumbai-listed unit for Rs... |
| 20.02.2026 | PE-led consortium to buy Novartis India unit in $159m deal | - |
| 20.02.2026 | Curt Smith: Fighting blood cancer is easier with a group effort | - |
| 18.02.2026 | Interim Report for the period October – December 2025 | Interim Report for the period October – December 2025
Wed, Feb 18, 2026 08:00 CET Report this content
A transformative year with record financial results
Events during the fourth quarter 2025 Leqembi® Iqlik™ was launched for weekly maintena... |
| 13.02.2026 | Prices, pipelines and patent cliffs: Inside pharma’s big reset | Pharma earnings weren’t the main focus for drugmakers this quarter.
“2025 was about understanding kind of the rules of the future of the game,” McKinsey Senior Partner Greg Graves told CNBC.
In addition to political dealings, companies are ... |
| 10.02.2026 | LinkedIn Thinkers Top 10 in Leadership for 2026 | Share
Share
Share
Share
Email
A Canon of Influence and Insight
In 2026 the leadership conversation has shifted. Executive influence is no longer measured solely by titles or corporate hierarchy, but by idea impact — the capacity to shape ho... |
| 10.02.2026 | «Дочка» Alphabet представила ИИ-движок для дизайна лекарств — вдвое точнее AlphaFold 3 | Isomorphic Labs, дочерняя компания Alphabet и сестринская структура Google DeepMind, представила IsoDDE (Isomorphic Labs Drug Design Engine) — единый вычислительный движок для проектирования лекарственных молекул. На самом сложном бенчмарке... |
| 04.02.2026 | Market Volatility Rocks US Stocks Amid Major Corporate Shifts and Mega-Mergers | US markets plunged. Tech and software stocks saw steep declines. Artificial intelligence concerns fueled investor anxiety. UBS reported robust earnings, beating forecasts. Its shares rose. Conversely, Novo Nordisk projected slowing growth. ... |
| 04.02.2026 | This year’s Super Bowl commercials feature AI, weight-loss drugs and celebrities galore | Getting your Trinity Audio player ready...
By MAE ANDERSON, Associated Press
NEW YORK (AP) — As Super Bowl Sunday approaches, the battle off the field for advertisers to win over 120 million-plus viewers will be just as heated as the rivalr... |
| 04.02.2026 | Santander falls nearly 4% amid plan to buy U.S. bank Webster for $12.2 billion | LONDON — European stocks opened in flat-to-higher territory on Wednesday amid a slew of corporate earnings reports in the region.
The pan-European Stoxx 600 was trading just above the flatline shortly after the market open.
The U.K.’s FTSE ... |
| 29.01.2026 | Ivonescimab Included in FirstWord Pharma's "The Drugs That Will Shape 2026" | HONG KONG, Jan. 29, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to share that the international industry media FirstWord Pharma released its list titled "Spotlight On: The Drugs That Will Shape 2026", providing an in-dep... |
| 29.01.2026 | uMotif Posts Strong Growth, Earns Market Accolades for eCOA Platform, Demonstrates Continued Clinical Trial Industry Leadership in 2025 | Everest Group gives uMotif highest possible technology rating in eCOA market assessment; Chief Scientific Officer Florence Mowlem PhD leads C-Path publication of industry-wide Event-Driven eDiary best practices in Nature Digital Medicine; f... |
| 28.01.2026 | HumanTrue Recognized as a Winner in the TransCelerate Protocol Review Challenge at SCOPE | HumanTrue has been named a winner in the TransCelerate Protocol Review Challenge at SCOPE, recognized for Best User Experience (UX) Design for Protocol Review. The award highlights HumanTrue's intuitive Schedule of Activities interface and ... |
| 27.01.2026 | Davos Spotlight | EVYD, Ministry of Health Brunei Darussalam and Novartis Foundation Launch National AI-Powered Cardiovascular Disease Prevention Initiative | DAVOS, Switzerland, Jan. 27, 2026 /PRNewswire/ -- At the 2026 World Economic Forum Annual Meeting in Davos, Dr. Giovanni Caforio, Chairman of the Board of Directors of Novartis, announced a major new partnership: the Novartis Foundation, th... |
| 24.01.2026 | Heart Attack Survivor and Social Media Powerhouse Dr. ShantaQuilette Carter-Williams to Take Center Stage at WomenHeart's 2026 Summit | WomenHeart has announced its 2026 Summit taking place February 1-3 at the Hilton Washington DC National Mall, The Wharf. Heart attack and stroke survivor Dr. ShantaQuilette Carter-Williams, a social media powerhouse with millions of followe... |
| 20.01.2026 | Novartis’ U.S. deal could shield it from tariffs, CEO tells CNBC | Swiss pharmaceutical giant Novartis expects to “not really” be exposed to tariffs by the middle of the year, CEO Vas Narasimhan told CNBC at Davos.
“We also have an agreement with the U.S. government that excludes us from any tariffs, we th... |
| 20.01.2026 | Another alliance of health care and AI signals why pharma stocks should be back in favor | - |
| 19.01.2026 | Here are the European exporters most exposed if Trump’s Greenland tariffs kick in | Trump has pledged to impose 10% tariffs on eight European countries from Feb. 1, ramping up his push to make Greenland a part of the United States.
The levy will rise to 25% from June 1, Trump said.
CNBC takes a look at some of the most exp... |
| 18.01.2026 | Swiss companies looking to tap into India opportunity, ramp up investments | - |
| 15.01.2026 | Commercial real estate deal-making slows again in November | Commercial real estate transaction volume was 10% lower year over year, with just 1,800 deals overall, according to monthly data provided by Moody’s as a media exclusive to CNBC’s Property Play.
Investors are leaning toward larger-scale acq... |
| 11.01.2026 | EpiBiologics Secures $107M Series B, Propelling Precision Protein Degradation for Cancer and Immunity | EpiBiologics closed a $107 million Series B. This investment accelerates its EpiTAC platform. The platform develops tissue-selective extracellular protein degraders. These target disease-driving membrane and soluble proteins. Lead candidate... |
